XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 81,769 Value ($000) $449 Avg Close $4.04 Range $3.14 - $6.07
Q4 2024
Shares 87,432 Value ($000) $296 Avg Close $3.22 Range $2.69 - $3.87
Q3 2024
Shares 59,208 Value ($000) $169 Avg Close $2.57 Range $2.03 - $3.04
Q2 2024
Shares 82,638 Value ($000) $186 Avg Close $2.02 Range $1.69 - $2.51
Q1 2024
Shares 58,092 Value ($000) $128 Avg Close $2.59 Range $2.00 - $3.26
Q4 2023
Shares 71,237 Value ($000) $167 Avg Close $1.85 Range $1.46 - $2.44
Q3 2023
Shares 71,237 Value ($000) $133 Avg Close $2.29 Range $1.73 - $2.78
Q1 2023
Shares 71,237 Value ($000) $116 Avg Close $1.25 Range $0.97 - $1.70
Q4 2022
Shares 25,829 Value ($000) $34 Avg Close $1.41 Range $1.14 - $1.70
Q3 2022
Shares 70,854 Value ($000) $111 Avg Close $1.65 Range $1.36 - $1.99
Q2 2022
Shares 70,854 Value ($000) $109 Avg Close $2.11 Range $1.25 - $2.72